PureTech Health plc (PTCHF)
OTCMKTS · Delayed Price · Currency is USD
1.750
0.00 (0.00%)
Jun 22, 2025, 8:00 PM EDT

PureTech Health Statistics

Total Valuation

PureTech Health has a market cap or net worth of 415.12 million. The enterprise value is 175.79 million.

Market Cap 415.12M
Enterprise Value 175.79M

Important Dates

The last earnings date was Wednesday, May 28, 2025.

Earnings Date May 28, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 240.25M
Shares Outstanding n/a
Shares Change (YoY) -7.34%
Shares Change (QoQ) -10.11%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 164.85M

Valuation Ratios

The trailing PE ratio is 7.76.

PE Ratio 7.76
Forward PE n/a
PS Ratio 85.98
PB Ratio 1.02
P/TBV Ratio 1.00
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 3.29
EV / Sales 33.45
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -1.31

Financial Position

The company has a current ratio of 9.33, with a Debt / Equity ratio of 0.41.

Current Ratio 9.33
Quick Ratio 9.19
Debt / Equity 0.41
Debt / EBITDA n/a
Debt / FCF -1.23
Interest Coverage -13.54

Financial Efficiency

Return on equity (ROE) is 6.41% and return on invested capital (ROIC) is -14.55%.

Return on Equity (ROE) 6.41%
Return on Assets (ROA) -13.10%
Return on Invested Capital (ROIC) -14.55%
Return on Capital Employed (ROCE) -24.21%
Revenue Per Employee 86,214
Profits Per Employee 955,536
Employee Count 56
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax -4.01M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -31.91% in the last 52 weeks. The beta is 0.90, so PureTech Health's price volatility has been similar to the market average.

Beta (5Y) 0.90
52-Week Price Change -31.91%
50-Day Moving Average 1.66
200-Day Moving Average 1.83
Relative Strength Index (RSI) 81.82
Average Volume (20 Days) 2,466

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, PureTech Health had revenue of 4.83 million and earned 53.51 million in profits. Earnings per share was 0.21.

Revenue 4.83M
Gross Profit -64.40M
Operating Income -135.87M
Pretax Income 23.77M
Net Income 53.51M
EBITDA -134.06M
EBIT -135.87M
Earnings Per Share (EPS) 0.21
Full Income Statement

Balance Sheet

The company has 378.69 million in cash and 165.58 million in debt, giving a net cash position of 213.11 million.

Cash & Cash Equivalents 378.69M
Total Debt 165.58M
Net Cash 213.11M
Net Cash Per Share n/a
Equity (Book Value) 407.93M
Book Value Per Share 1.73
Working Capital 344.87M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -134.37 million and capital expenditures -11,000, giving a free cash flow of -134.38 million.

Operating Cash Flow -134.37M
Capital Expenditures -11,000
Free Cash Flow -134.38M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -2,814.19%
Pretax Margin 492.42%
Profit Margin 1,108.33%
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

PureTech Health does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 7.34%
Shareholder Yield 7.34%
Earnings Yield 12.89%
FCF Yield -32.37%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

PureTech Health has an Altman Z-Score of 1.88 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.88
Piotroski F-Score 4